Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Annals of Hematology|July 16, 2026
Multidisciplinary approach to managing GPRC5D-related adverse events in relapsed or refractory multiple myeloma patientsNicolas Albrecht, Eline Boeckx, Jo Caers, et al.
Haematologica|November 8, 2011
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatmentsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Molecules (Basel, Switzerland)|January 20, 2021
New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death PathwaysFatima Bouhtit, Mehdi Najar, Douâa Moussa Agha, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2015
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximabKristoff Muylle, Patrick Flamen, Danielle J Vugts, et al.
Journal of Clinical Medicine|March 8, 2020
The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal CellsKarolien Buyl, Makram Merimi, Robim M Rodrigues, et al.
Frontiers in Cell and Developmental Biology|February 12, 2024
Treatment of medication-related osteonecrosis of the jaw with cell therapyCyril Lucien Bouland, Rokneddine Javadian, Sarah Gilis, et al.
Annals of Medicine|June 18, 2013
Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physiciansJo Caers, Marie-Christiane Vekemans, Greet Bries, et al.
Acta Clinica Belgica|April 27, 2026
Belgian recommendations for tissue diagnosis of amyloidosisAmélie Dendooven, Annelore Vandendriessche, Priyanka Joseph Koshy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter StudyBasile Stamatopoulos, Thomas Smith, Emerence Crompot, et al.
Annals of Hematology|June 27, 2019
Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myelomaIvan Spicka, Enrique M Ocio, Heather E Oakervee, et al.
Pageof 10